Genetic profiling as a marker for risk of sudden cardiac death

Area of Science:

• Cardiology
• Genomic Medicine
• Medical Technology

Background:

• Implantable cardioverter-defibrillators (ICDs) reduce mortality in heart failure patients with ejection fraction ≤35%.
• Empirical ICD implantation is costly, with over half of patients not requiring device therapy long-term.
• Current risk stratification methods have low predictive value for identifying patients who will benefit from ICDs.

Purpose of the Study:

• To explore the potential of genomic medicine in identifying genetic susceptibility to sudden arrhythmic death.
• To discuss optimizing the use of implantable cardioverter-defibrillators in heart failure patients.

Main Methods:

• Review of clinical trial data and genetic studies on sudden cardiac death.
• Analysis of common genetic variations (polymorphisms) associated with cardiac electrophysiology.
• Evaluation of the predictive value of current clinical stratification tests.

Main Results:

• The number of patients needing treatment to prevent one sudden death with ICDs has increased over the past decade.
• Genetic studies have identified common polymorphisms linked to cardiac electrophysiology that may increase arrhythmic risk in heart failure.
• Existing clinical tests for risk stratification have limited positive predictive value.

Conclusions:

• Current indications for ICD implantation include many patients who may not benefit.
• Identifying genetic variations associated with ventricular arrhythmia vulnerability can optimize medical resource use.
• Genomic approaches may enable rapid identification of high-risk patient subgroups for targeted interventions.